{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:30:06Z","timestamp":1776403806972,"version":"3.51.2"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":1510,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007671","name":"Fundaci\u00f3n para la Investigaci\u00f3n y la Prevenci\u00f3n del Sida en Espa\u00f1a","doi-asserted-by":"publisher","award":["TOH-VIH\/05"],"award-info":[{"award-number":["TOH-VIH\/05"]}],"id":[{"id":"10.13039\/501100007671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007671","name":"Fundaci\u00f3n para la Investigaci\u00f3n y la Prevenci\u00f3n del Sida en Espa\u00f1a","doi-asserted-by":"publisher","award":["TOH-VIH\/08"],"award-info":[{"award-number":["TOH-VIH\/08"]}],"id":[{"id":"10.13039\/501100007671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007671","name":"Fundaci\u00f3n para la Investigaci\u00f3n y la Prevenci\u00f3n del Sida en Espa\u00f1a","doi-asserted-by":"publisher","award":["TOH-VIH\/12"],"award-info":[{"award-number":["TOH-VIH\/12"]}],"id":[{"id":"10.13039\/501100007671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007671","name":"Fundaci\u00f3n para la Investigaci\u00f3n y la Prevenci\u00f3n del Sida en Espa\u00f1a","doi-asserted-by":"publisher","award":["TOH-VIH\/13"],"award-info":[{"award-number":["TOH-VIH\/13"]}],"id":[{"id":"10.13039\/501100007671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007671","name":"Fundaci\u00f3n para la Investigaci\u00f3n y la Prevenci\u00f3n del Sida en Espa\u00f1a","doi-asserted-by":"publisher","award":["TOH-VIH\/14"],"award-info":[{"award-number":["TOH-VIH\/14"]}],"id":[{"id":"10.13039\/501100007671","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministry of Health (Madrid, Spain)","award":["EC11-150"],"award-info":[{"award-number":["EC11-150"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/01229"],"award-info":[{"award-number":["PI13\/01229"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/01770"],"award-info":[{"award-number":["PI13\/01770"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Departament de Salut de la Generalitat de Catalunya'","doi-asserted-by":"crossref","award":["Pla Estrat\u00e8gic de Recerca i Innovaci\u00f3 en Salut -PERIS- 2016\/2020"],"award-info":[{"award-number":["Pla Estrat\u00e8gic de Recerca i Innovaci\u00f3 en Salut -PERIS- 2016\/2020"]}],"id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain","award":["80:20"],"award-info":[{"award-number":["80:20"]}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1111\/ajt.14996","type":"journal-article","created":{"date-parts":[[2018,7,2]],"date-time":"2018-07-02T13:02:31Z","timestamp":1530536551000},"page":"2513-2522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Direct-acting antivirals are effective and safe in HCV\/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study"],"prefix":"10.1016","volume":"18","author":[{"given":"Christian","family":"Manzardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Londo\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LLu\u00eds","family":"Castells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milagros","family":"Testillano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Luis Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Pe\u00f1afiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Subirana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Luisa Gonz\u00e1lez-Di\u00e9guez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Calvo-Pulido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Xiol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Cuervas-Mons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Manuel Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trinidad","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Ignacio Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 R.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santos","family":"del Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan I.","family":"Esteban-Mur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"de la Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Rimola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Miro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1111\/ajt.14996_bib1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/jhep.2002.31773","article-title":"Hepatitis C virus kinetics during and immediately after liver transplantation","volume":"35","author":"Garcia-Retortillo","year":"2002","journal-title":"Hepatology."},{"issue":"6","key":"10.1111\/ajt.14996_bib2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1053\/j.gastro.2012.02.011","article-title":"Viral hepatitis in liver transplantation","volume":"142","author":"Crespo","year":"2012","journal-title":"Gastroenterology."},{"issue":"1","key":"10.1111\/ajt.14996_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/QAD.0000000000000516","article-title":"Therapy with boceprevir or telaprevir in HIV\/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation","volume":"29","author":"Antonini","year":"2015","journal-title":"AIDS."},{"issue":"5","key":"10.1111\/ajt.14996_bib4","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1053\/j.gastro.2007.03.041","article-title":"Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study","volume":"132","author":"Carrion","year":"2007","journal-title":"Gastroenterology."},{"issue":"3","key":"10.1111\/ajt.14996_bib5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.21090","article-title":"Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation","volume":"43","author":"Blasco","year":"2006","journal-title":"Hepatology."},{"issue":"3","key":"10.1111\/ajt.14996_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1600-6143.2007.02126.x","article-title":"Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation","volume":"8","author":"Berenguer","year":"2008","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.14996_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2014.07.034","article-title":"Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study","volume":"62","author":"Castells","year":"2015","journal-title":"J Hepatol."},{"issue":"5","key":"10.1111\/ajt.14996_bib8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/ajt.12668","article-title":"Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients","volume":"14","author":"Terrault","year":"2014","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.14996_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2015.05.010","article-title":"Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease","volume":"149","author":"Charlton","year":"2015","journal-title":"Gastroenterology."},{"issue":"6","key":"10.1111\/ajt.14996_bib10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(16)00052-9","article-title":"Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial","volume":"16","author":"Manns","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"10.1111\/ajt.14996_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/lt.24366","article-title":"Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: real-wolrd experience from HCV-TARGET","volume":"22","author":"Brown","year":"2016","journal-title":"Liver Transpl."},{"issue":"5","key":"10.1111\/ajt.14996_bib12","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/hep.28446","article-title":"Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence","volume":"63","author":"Poordad","year":"2016","journal-title":"Hepatology."},{"issue":"12","key":"10.1111\/ajt.14996_bib13","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/apt.13629","article-title":"Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy","volume":"43","author":"Campos-Varela","year":"2016","journal-title":"Aliment Pharmacol Ther."},{"issue":"11","key":"10.1111\/ajt.14996_bib14","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1093\/jac\/dkw270","article-title":"IFN-free therapy for HIV\/HCV-coinfected patients within the liver transplant setting","volume":"71","author":"Londo\u00f1o","year":"2016","journal-title":"J Antimicrob Chemother."},{"issue":"1","key":"10.1111\/ajt.14996_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5604\/16652681.1226819","article-title":"Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplant","volume":"16","author":"Castells","year":"2017","journal-title":"Ann Hepatol."},{"issue":"2","key":"10.1111\/ajt.14996_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofx065","article-title":"Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection","volume":"4","author":"Guaraldi","year":"2017","journal-title":"Open Forum Infect Dis."},{"issue":"1","key":"10.1111\/ajt.14996_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/TP.0000000000001928","article-title":"Sofosbuvir-based regimens in HIV\/HCV coinfected patients after liver transplantation","volume":"102","author":"Antonini","year":"2018","journal-title":"Transplantation."},{"key":"10.1111\/ajt.14996_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL recommendations on treatment of hepatitis C 2016","volume":"66","year":"2017","journal-title":"J Hepatol."},{"key":"10.1111\/ajt.14996_bib19","series-title":"Logistic Regression for Matched Case-Control Studies","author":"Hosmer","year":"2013"},{"issue":"25","key":"10.1111\/ajt.14996_bib20","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","article-title":"An interferon-free antiviral regimen for HCV after liver transplantation","volume":"371","author":"Kwo","year":"2014","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1111\/ajt.14996_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MOT.0000000000000197","article-title":"Hepatitis C treatment for patients post liver transplant","volume":"20","author":"Mari\u00f1o","year":"2015","journal-title":"Curr Opin Organ Transplant."},{"issue":"3","key":"10.1111\/ajt.14996_bib22","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2014.04.037","article-title":"A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy","volume":"61","author":"Burton","year":"2014","journal-title":"J Hepatol."},{"key":"10.1111\/ajt.14996_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2013.08.018","article-title":"Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience","volume":"60","author":"Coilly","year":"2014","journal-title":"J Hepatol."},{"issue":"6","key":"10.1111\/ajt.14996_bib24","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hep.27770","article-title":"Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant","volume":"61","author":"Pungpapong","year":"2015","journal-title":"Hepatology."},{"key":"10.1111\/ajt.14996_bib25","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1016\/S0168-8278(15)30168-9","article-title":"A Phase 3, randomised, open-label study to evaluate the efficacy and safety of 12 and 8 weeks of simeprevir (SMV) plus sofosbuvir (SOF) in treatment-na\u00efve and -experienced patients with chronic HCV genotype 1 infection without cirrhosis: OPTIMIST-1","volume":"62","author":"Kwo","year":"2015","journal-title":"J Hepatol."},{"issue":"1","key":"10.1111\/ajt.14996_bib26","first-page":"1","article-title":"Successful sofosbuvir-based therapy in HIV\/HCV coinfected liver transplant recipients with recurrent HCV infection","volume":"30","author":"Grant","year":"2015","journal-title":"AIDS"},{"issue":"2","key":"10.1111\/ajt.14996_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/lt.24027","article-title":"Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus\/hepatitis C virus-coinfected liver transplant recipients","volume":"21","author":"Campos-Varela","year":"2015","journal-title":"Liver Transpl."},{"key":"10.1111\/ajt.14996_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29918","article-title":"12 weeks of a Ribavirin-free sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation","author":"Houssel-Debry","year":"2018","journal-title":"Hepatology."}],"updated-by":[{"DOI":"10.1111\/ajt.15244","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000}}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14996","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352224787X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S160061352224787X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14996\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T13:24:46Z","timestamp":1693747486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S160061352224787X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S160061352224787X"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14996","relation":{"erratum":[{"id-type":"doi","id":"10.1111\/ajt.15244","asserted-by":"object"}]},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct-acting antivirals are effective and safe in HCV\/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}